Regulus Therapeutics
RGLS
#8240
Rank
HK$1.43 B
Marketcap
HK$21.72
Share price
9.80%
Change (1 day)
24.93%
Change (1 year)

EPS for Regulus Therapeutics (RGLS)

EPS in 2023 (TTM): -HK$13.25

According to Regulus Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$13.11. In 2022 the company made an earnings per share (EPS) of -HK$14.43 an increase over its 2021 EPS that were of -HK$25.36.

EPS history for Regulus Therapeutics from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$13.25-8.18%
2022-HK$14.43-43.12%
2021-HK$25.36-40.55%
2020-HK$42.66-50%
2019-HK$85.32-80.36%
2018-HK$434.37-57.8%
2017-HK$1,029-28.66%
2016-HK$1,44342.2%
2015-HK$1,015-14.84%
2014-HK$1,191156%
2013-HK$465.39-98.75%
2012-HK$37,243

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$27.15-307.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$24.67-288.18%๐Ÿ‡ซ๐Ÿ‡ท France
HK$143.19-1,192.31%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$15.40-217.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$31.88 143.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$11.17-14.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.79-334.91%๐Ÿ‡บ๐Ÿ‡ธ USA